Open access
231
Views
58
CrossRef citations to date
0
Altmetric
Original Research
Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany
Qing Qiao1 Global Medicines Development, AstraZeneca, Gothenburg, Sweden
, Mario JNM Ouwens1 Global Medicines Development, AstraZeneca, Gothenburg, Sweden
, Susan Grandy2 Global Medicines Development, AstraZeneca, Gaithersburg, MD, USA
, Kristina Johnsson1 Global Medicines Development, AstraZeneca, Gothenburg, Sweden
& Karel Kostev3 Epidemiology and Evidence-Based Medicine, Real-World Evidence Solutions, IMS Health, Frankfurt am Main, GermanyCorrespondence[email protected]
Pages 201-205
|
Published online: 28 Jun 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.